Original
Lixisenatida en pacientes con diabetes tipo 2 y obesidad: más allá del control glucémico
Lixisenatide in patients with type 2 diabetes and obesity: Beyond glycaemic control
M. Mar Roca-Rodrígueza,
, María Teresa Muros de Fuentesb, Gonzalo Piédrola-Marotob, Miguel Quesada-Charnecoc, Silvia Maraver-Selfad, Francisco J. Tinahonesd,e, Isabel Mancha-Doblasd
Autor para correspondencia
a UGC de Endocrinología y Nutrición, Hospital Universitario Puerta del Mar, Cádiz, España
b UGC de Endocrinología y Nutrición, Hospital Virgen de las Nieves, Granada, España
c UGC de Endocrinología y Nutrición, Hospital San Cecilio, Granada, España
d UGC de Endocrinología y Nutrición, Hospital Clínico Universitario Virgen de la Victoria y Hospital Regional Universitario, Málaga, España
e Instituto de Investigación Biomédica de Málaga (IBIMA), Complejo Hospitalario de Málaga (Virgen de la Victoria)/Universidad de Málaga; CIBER Pathophysiology of Obesity and Nutrition (CB06/03), Málaga, España
Leído
13810
Vecesse ha leído el artículo
1148
Total PDF
12662
Total HTML
| año/Mes | Html | Total | |
|---|---|---|---|
| 2025 12 | 18 | 3 | 21 |
| 2025 11 | 69 | 24 | 93 |
| 2025 10 | 74 | 8 | 82 |
| 2025 9 | 94 | 14 | 108 |
| 2025 8 | 126 | 9 | 135 |
| 2025 7 | 179 | 10 | 189 |
| 2025 6 | 275 | 9 | 284 |
| 2025 5 | 236 | 5 | 241 |
| 2025 4 | 364 | 7 | 371 |
| 2025 3 | 430 | 9 | 439 |
| 2025 2 | 188 | 5 | 193 |
| 2025 1 | 381 | 3 | 384 |
| 2024 12 | 529 | 6 | 535 |
| 2024 11 | 384 | 12 | 396 |
| 2024 10 | 335 | 10 | 345 |
| 2024 9 | 544 | 5 | 549 |
| 2024 8 | 588 | 7 | 595 |
| 2024 7 | 468 | 4 | 472 |
| 2024 6 | 202 | 6 | 208 |
| 2024 5 | 237 | 10 | 247 |
| 2024 4 | 292 | 7 | 299 |
| 2024 3 | 134 | 10 | 144 |
| 2024 2 | 186 | 5 | 191 |
| 2024 1 | 242 | 6 | 248 |
| 2023 12 | 220 | 7 | 227 |
| 2023 11 | 270 | 10 | 280 |
| 2023 10 | 263 | 7 | 270 |
| 2023 9 | 180 | 4 | 184 |
| 2023 8 | 197 | 10 | 207 |
| 2023 7 | 165 | 3 | 168 |
| 2023 6 | 190 | 5 | 195 |
| 2023 5 | 206 | 5 | 211 |
| 2023 4 | 201 | 8 | 209 |
| 2023 3 | 163 | 4 | 167 |
| 2023 2 | 95 | 6 | 101 |
| 2022 1 | 101 | 3 | 104 |
| 2022 12 | 64 | 6 | 70 |
| 2022 11 | 119 | 8 | 127 |
| 2022 10 | 77 | 13 | 90 |
| 2022 9 | 90 | 15 | 105 |
| 2022 8 | 80 | 20 | 100 |
| 2022 7 | 54 | 14 | 68 |
| 2022 6 | 57 | 10 | 67 |
| 2022 5 | 70 | 10 | 80 |
| 2022 4 | 75 | 7 | 82 |
| 2022 3 | 116 | 11 | 127 |
| 2022 2 | 117 | 6 | 123 |
| 2021 1 | 66 | 9 | 75 |
| 2021 12 | 80 | 12 | 92 |
| 2021 11 | 89 | 9 | 98 |
| 2021 10 | 67 | 13 | 80 |
| 2021 9 | 47 | 20 | 67 |
| 2021 8 | 35 | 9 | 44 |
| 2021 7 | 24 | 13 | 37 |
| 2021 6 | 35 | 5 | 40 |
| 2021 5 | 26 | 10 | 36 |
| 2021 4 | 65 | 21 | 86 |
| 2021 3 | 79 | 16 | 95 |
| 2021 2 | 94 | 10 | 104 |
| 2020 1 | 53 | 18 | 71 |
| 2020 12 | 32 | 10 | 42 |
| 2020 11 | 28 | 12 | 40 |
| 2020 10 | 26 | 8 | 34 |
| 2020 9 | 37 | 14 | 51 |
| 2020 8 | 42 | 20 | 62 |
| 2020 7 | 17 | 18 | 35 |
| 2020 6 | 21 | 17 | 38 |
| 2020 5 | 21 | 9 | 30 |
| 2020 4 | 15 | 4 | 19 |
| 2020 3 | 27 | 8 | 35 |
| 2020 2 | 24 | 2 | 26 |
| 2020 1 | 20 | 4 | 24 |
| 2019 12 | 37 | 10 | 47 |
| 2019 11 | 22 | 6 | 28 |
| 2019 10 | 19 | 6 | 25 |
| 2019 9 | 17 | 5 | 22 |
| 2019 8 | 12 | 11 | 23 |
| 2019 7 | 23 | 4 | 27 |
| 2019 6 | 55 | 20 | 75 |
| 2019 5 | 134 | 35 | 169 |
| 2019 4 | 53 | 30 | 83 |
| 2019 3 | 13 | 12 | 25 |
| 2019 2 | 18 | 7 | 25 |
| 2019 1 | 8 | 2 | 10 |
| 2018 12 | 18 | 9 | 27 |
| 2018 11 | 23 | 7 | 30 |
| 2018 10 | 34 | 24 | 58 |
| 2018 9 | 48 | 2 | 50 |
| 2018 8 | 29 | 6 | 35 |
| 2018 7 | 27 | 2 | 29 |
| 2018 6 | 25 | 5 | 30 |
| 2018 5 | 27 | 2 | 29 |
| 2018 4 | 22 | 2 | 24 |
| 2018 3 | 17 | 3 | 20 |
| 2018 2 | 21 | 1 | 22 |
| 2018 1 | 23 | 4 | 27 |
| 2017 12 | 31 | 2 | 33 |
| 2017 11 | 54 | 7 | 61 |
| 2017 10 | 48 | 16 | 64 |
| 2017 9 | 63 | 4 | 67 |
| 2017 8 | 55 | 8 | 63 |
| 2017 7 | 100 | 6 | 106 |
| 2017 6 | 332 | 15 | 347 |
| 2017 5 | 360 | 25 | 385 |
| 2017 4 | 39 | 12 | 51 |
| 2017 3 | 5 | 19 | 24 |
| 2017 2 | 4 | 12 | 16 |
| 2016 1 | 4 | 10 | 14 |
| 2016 12 | 1 | 20 | 21 |
| 2016 11 | 12 | 38 | 50 |
| 2016 10 | 13 | 48 | 61 |
| 2016 9 | 1 | 14 | 15 |
Mostrar todo
